|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/067 | |
| A61K 31/7072 | |||
| A61P 31/14 | |||
| C07B 59/00 |
| (11) | Patento numeris | 2984097 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14722955.3 |
| Europos patento paraiškos padavimo data | 2014-04-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/034018 |
| Data | 2014-04-14 |
| (87) | Numeris | WO 2014/169278 |
| Data | 2014-10-16 |
| (30) | Numeris | Data | Šalis |
| 201361811464 P | 2013-04-12 | US |
| (72) |
DESHPANDE, Milind, US
WILES, Jason Allan, US
HASHIMOTO, Akihiro, US
PHADKE, Avinash, US
|
| (73) |
Achillion Pharmaceuticals, Inc.,
300 George Street, New Haven, CT 06511,
US
|
| (54) | HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV |
| HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV |